Recombinant and blood creatine increased Patient Reports February 13, 2012

Recombinant Side Effects Report #5966551-3
Recombinant side effect was reported by a Health Professional from CANADA on Nov 18, 2008. Female patient, 20 years of age, was diagnosed with thrombocytopenia and was treated with Recombinant. After drug was administered, patient experienced the following side effects: analgesia, blood creatine increased, blood urea increased, depressed level of consciousness, oedema peripheral, pulmonary oedema, respiratory depression, somnolence. Recombinant dosage: unknown. During the same period patient was treated with DAPSONE, AMITRIPTYLINE, NEUPOGEN, MORPHINE, PHENOBARBITAL. Patient recovered.